Cargando…
Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review
CDH1, as a tumor suppressor gene, contributes sporadic breast cancer (BC) progression. However, the association between CDH1 hypermethylation and BC, and its clinicopathological significance remains unclear. We conducted a meta-analysis to investigate the relationship between the CDH1 methylation pr...
Autores principales: | Huang, Ruixue, Ding, Ping, Yang, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4583122/ https://www.ncbi.nlm.nih.gov/pubmed/26425077 http://dx.doi.org/10.2147/DDDT.S86929 |
Ejemplares similares
-
Clinicopathological significance and potential drug targeting of CDH1 in lung cancer: a meta-analysis and literature review
por: Yu, Qiaowen, et al.
Publicado: (2015) -
The clinicopathological significance and drug target potential of FHIT in breast cancer, a meta-analysis and literature review
por: Su, Yunshu, et al.
Publicado: (2015) -
The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review
por: Zeng, Wei, et al.
Publicado: (2015) -
Comments on a meta-analysis and systematic review of the clinicopathological significance of CDH1 in gastric cancer
por: Tu, Chao, et al.
Publicado: (2016) -
Clinicopathological significance and potential drug target of RUNX3 in breast cancer
por: Yu, Ying-Ying, et al.
Publicado: (2014)